Gland Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma has submitted a routine quarterly compliance certificate from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited (formerly Link Intime), for the quarter ended December 31, 2025. The certificate confirms that any securities received from depository participants for dematerialization were properly processed and reflected in the company's register of members within SEBI's prescribed timelines. Importantly, the RTA noted that no requests for dematerialization or rematerialization were received during the quarter. The filing is purely procedural and was signed by the Company Secretary on January 13, 2026.
This is a standard regulatory compliance filing with no material impact on the business, financials, or shareholders. Investors can safely ignore it as it carries no actionable information.